Deshpande Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-01-2025
- Paid Up Capital ₹ 0.10 M
as on 02-01-2025
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 1.25 M
as on 02-01-2025
- Revenue -65.53%
(FY 2017)
- Profit -24.93%
(FY 2017)
- Ebitda -13.95%
(FY 2017)
- Net Worth 12.54%
(FY 2017)
- Total Assets -22.75%
(FY 2017)
About Deshpande Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.25 M.
Amit Deshpande and Ashwin Deshpande serve as directors at the Company.
- CIN/LLPIN
U52311MP2010PTC023337
- Company No.
023337
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2010
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Deshpande Laboratories Private Limited offer?
Deshpande Laboratories Private Limited offers a wide range of products and services, including Chemical Plants & Machinery, Distillation Units, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Mosquito & Insect Repellent, Mosquito Repellent.
Who are the key members and board of directors at Deshpande Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Deshpande  | Managing Director | 07-Apr-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashwin Deshpande | Director | 07-Apr-2010 | Current |
Financial Performance of Deshpande Laboratories.
Deshpande Laboratories Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 65.53% decrease. The company also saw a substantial fall in profitability, with a 24.93% decrease in profit. The company's net worth Soared by an impressive increase of 12.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deshpande Laboratories?
In 2017, Deshpande Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 17 Sep 2011 | ₹1.25 M | Open |
How Many Employees Work at Deshpande Laboratories?
Unlock and access historical data on people associated with Deshpande Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deshpande Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deshpande Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
